1Pouplard C, May MA, Regina S,et al. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies[J]. Br J Haematol, 2005,128:837-841.
2Warkentin TE, Greinacher A. Heparininduced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J]. Chest, 2004, 126:311-337.
3Greinacher A, Farner B, Kroll H, et al. Clinical features of heparininduced thrombocytopenia induding risk factors for thrombosis: A retrospective analysis of 408 patients[J]. Thromb Haemost, 2005,94: 132-135.
5Kathleen S, Theodore EW,Andreas O. Heparin-induced thrombocytopenia in intensive care patients [J]. Crit Care Med, 2007, 35: 1165-1176.
6Chong BH, Magnani HN. Danaparoid for the treatment of heparin-induced thrombocytopenia [A]. In: Warkentin TE, Greinacher A Eds. Heparin-Induced Thrombocytopenia [M]. Third Edition. New York, Marcel Dekker, 2004:371-398.
7Greinacher A. Lepirudin: A bivalent directthrombin inhibitor for anticoagulation therapy [J]. Expert Rev Cardiovasc Ther, 2004, 2: 339-357.
8Reichert MG, MacGregor DA, Kincaid EH, et al. Excessive argatroban anticoagulation for heparin-induced thrombocytopenia[J]. Ann Pharmacother, 2003,37 : 652-654.
9Levine RL, Hursting MJ, McCollum D. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction [J]. Chest 2006,129 : 1167-1175.
10Warkentin TE. Should vitamin K be administered when HIT is diagnosed after administration of coumarin[J]. Thromb Haemost,2006,4: 894-896.
3Levi M. The coagulant response in sepsis and inflammation[J].Hamost Aseologie,2010,30( 1):10-16.
4Levi M, Van der Poll T, Ten Cate H, et al. The cytokine-mediated imbalance between coagulation and anticoagulantmechanisms in sepsis and endotoxemia[J]. Eur J ClinInvest,1997,27(1):3-9.
5Schouten M, Wiersinga WJ, Lervi M, et al. Inflammation,endothelium, and coagulation in sepsis[J]. LeukocBiol,2008,83(3):536-545.
6Levi M, Schouten M. Coagulation and platelet disorders in criticallyill patients[J]. Minerva- Anestesiol,2010,76(l 0):851-859.
7HuiP, Cook DJ, Lim W, et al. The frequency and clinicalsignificance of thrombocytopenia complicating criticalillness: a systematic review[J]. Chest,2011,139(2):271-278.
9Vandijck DM,Donahoe L, Clarke FJ,et al. Risk markersfor thromboytopenia in critically ill patients: a prospectiveanalysis[J]. Pharmacotherapy,2002,22(7):803-813.
10Oguzulgen IK, Ozis T, Gursel G. Is the fall in platelet countassociated with intensive care unit acquired pneumonia.[J].Swiss Med Wkly,2004,134(29-30):430-434.
